These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3553437

  • 1. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP.
    J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
    [Abstract] [Full Text] [Related]

  • 2. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO.
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [Abstract] [Full Text] [Related]

  • 3. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 4. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A.
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [Abstract] [Full Text] [Related]

  • 5. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 6. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
    Guruangan S, Dunkel IJ, Goldman S, Garvin JH, Rosenblum M, Boyett JM, Gardner S, Merchant TE, Gollamudi S, Finlay JL.
    J Clin Oncol; 1998 Jul 15; 16(7):2486-93. PubMed ID: 9667268
    [Abstract] [Full Text] [Related]

  • 7. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M.
    J Neurooncol; 1995 Nov 15; 26(2):111-23. PubMed ID: 8787853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autologous bone-marrow transplantation: host effects of high-dose BCNU.
    Takvorian T, Parker LM, Hochberg FH, Canellos GP.
    J Clin Oncol; 1983 Oct 15; 1(10):610-20. PubMed ID: 6366127
    [Abstract] [Full Text] [Related]

  • 11. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL, Fay JW, Herzig GP, Herzig RH, Weiner RS, Wolff SN, Lazarus HM, Karanes C, Ross WE, Kramer BS.
    Cancer; 1983 Nov 15; 52(10):1792-802. PubMed ID: 6354414
    [Abstract] [Full Text] [Related]

  • 12. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN, Phillips GL, Herzig GP.
    Cancer Treat Rep; 1987 Feb 15; 71(2):183-5. PubMed ID: 3026626
    [Abstract] [Full Text] [Related]

  • 13. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas.
    Heideman RL, Douglass EC, Krance RA, Fontanesi J, Langston JA, Sanford RA, Kovnar EH, Ochs J, Kuttesch J, Jenkins JJ.
    J Clin Oncol; 1993 Aug 15; 11(8):1458-65. PubMed ID: 8336185
    [Abstract] [Full Text] [Related]

  • 14. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT.
    J Neurosurg; 1981 Apr 15; 54(4):455-60. PubMed ID: 6259300
    [Abstract] [Full Text] [Related]

  • 15. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP, Brown LD, Arusell RM, Earle JD, O'Fallon JR, Buckner JC, Scheithauer BW, Krook JE, Tschetter LK, Maier JA.
    J Clin Oncol; 1993 Jul 15; 11(7):1316-21. PubMed ID: 8315428
    [Abstract] [Full Text] [Related]

  • 16. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK, Selby PJ, Perren TJ, Dearnaley DP, Whitton A, Ashley S, Workman P, Bloom HJ, McElwain TJ.
    Br J Cancer; 1988 Dec 15; 58(6):779-82. PubMed ID: 2852028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.